Publication for MS4A1 and CNR2
| Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
|---|---|---|---|---|---|---|
| hsa | MS4A1 | membrane spanning 4-domains A1 | 931 | [link] | ||
| hsa | CNR2 | cannabinoid receptor 2 | 1269 |
| Pubmed ID | Priority | Text |
|---|---|---|
| 31209404 | 0.78 | CB2 into two subclusters (Fig. 5c and Supplementary Fig. 5c): the first of these (CB2a), expressing the B cell markers CD19 and CD20 (MS4A1), demonstrated upregulation of genes typical of naive B cells, including high levels of IGHD, IGHM, TCL1A and IL4R, and had nearly undetectable expression of CD27; the other cluster (CB2b) expressed genes known to be upregulated in plasmacytoid DCs (pDCs) (Fig. 5c and Supplementary Fig. 5c), including PTPRS, GZMB, CLEC4C, CD123 (IL3RA) and CD317 (BST2). |
| 23299999 | 0.71 | CB2-GFP line were exposed to THC, the extracellular expression of CB2 by CD20+ B cells was also down-regulated when PBMC were exposed to THC in the range of 0.5 to 2.0 muM (results not shown). |
| 0.53 | CB2 or (B) following fixation and permeabilization for detection of total cellular CB2 expression as previously described in Figure 2, followed by counterstaining with lineage-specific fluorescent-conjugated antibodies for detection of CD20+ B cells (top), CD3+ T cells (middle), and CD13+ monocytes (bottom). |
The preparation time of this page was 0.0 [sec].
